913 related articles for article (PubMed ID: 16499646)
41. The relevance of microbial allergens to the IgE antibody repertoire in atopic and nonatopic eczema.
Reefer AJ; Satinover SM; Wilson BB; Woodfolk JA
J Allergy Clin Immunol; 2007 Jul; 120(1):156-63. PubMed ID: 17507082
[TBL] [Abstract][Full Text] [Related]
42. Specific IgE of common foods in Chinese children with eczema.
Hon KL; Chan IH; Chow CM; Wang SS; Lam CW; Ng PC; Leung TF
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):50-3. PubMed ID: 20609136
[TBL] [Abstract][Full Text] [Related]
43. The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients.
Tsunemi Y; Komine M; Sekiya T; Saeki H; Nakamura K; Hirai K; Kakinuma T; Kagami S; Fujita H; Asano N; Tanida Y; Wakugawa M; Torii H; Tamaki K
Exp Dermatol; 2004 Nov; 13(11):715-9. PubMed ID: 15500644
[TBL] [Abstract][Full Text] [Related]
44. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
Gu CY; Gu L; Dou X
Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
[TBL] [Abstract][Full Text] [Related]
45. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Hartl D; Latzin P; Zissel G; Krane M; Krauss-Etschmann S; Griese M
Am J Respir Crit Care Med; 2006 Jun; 173(12):1370-6. PubMed ID: 16543550
[TBL] [Abstract][Full Text] [Related]
46. The role of chemokines in exercise-induced bronchoconstriction in asthma.
Tahan F; Karaaslan C; Aslan A; Kiper N; Kalayci O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):819-25. PubMed ID: 16802769
[TBL] [Abstract][Full Text] [Related]
47. Glucocorticoid-induced tumour necrosis factor receptor (GITR) and its ligand (GITRL) in atopic dermatitis.
Baumgartner-Nielsen J; Vestergaard C; Thestrup-Pedersen K; Deleuran M; Deleuran B
Acta Derm Venereol; 2006; 86(5):393-8. PubMed ID: 16955181
[TBL] [Abstract][Full Text] [Related]
48. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.
Kataoka Y
J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072
[TBL] [Abstract][Full Text] [Related]
49. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
50. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
Holm JG; Hurault G; Agner T; Clausen ML; Kezic S; Tanaka RJ; Thomsen SF
Dermatology; 2021; 237(4):513-520. PubMed ID: 33730733
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough.
Hartl D; Griese M; Nicolai T; Zissel G; Prell C; Konstantopoulos N; Gruber R; Reinhardt D; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2005 Apr; 115(4):728-36. PubMed ID: 15805991
[TBL] [Abstract][Full Text] [Related]
52. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.
Saeki H; Tamaki K
J Dermatol Sci; 2006 Aug; 43(2):75-84. PubMed ID: 16859899
[TBL] [Abstract][Full Text] [Related]
53. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy.
Miyahara H; Okazaki N; Nagakura T; Korematsu S; Izumi T
Clin Exp Allergy; 2011 Feb; 41(2):186-91. PubMed ID: 21054588
[TBL] [Abstract][Full Text] [Related]
54. Antigen specific cytokine response in pediatric patients with atopic dermatitis.
Bordignon V; Sinagra JL; Trento E; Pietravalle M; Capitanio B; Cordiali Fei P
Pediatr Allergy Immunol; 2005 Mar; 16(2):113-20. PubMed ID: 15787867
[TBL] [Abstract][Full Text] [Related]
55. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis.
van der Aa LB; Lutter R; Heymans HS; Smids BS; Dekker T; van Aalderen WM; Sillevis Smitt JH; Knippels LM; Garssen J; Nauta AJ; Sprikkelman AB;
Clin Exp Allergy; 2012 Apr; 42(4):531-9. PubMed ID: 22092915
[TBL] [Abstract][Full Text] [Related]
56. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
Jenerowicz D; Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
[TBL] [Abstract][Full Text] [Related]
57. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
[TBL] [Abstract][Full Text] [Related]
58. Increased bronchial NO output in severe atopic eczema in children and adolescents.
Linkosalo L; Lehtimäki L; Laitinen J; Kaila M; Holm K; Moilanen E
Pediatr Allergy Immunol; 2008 Aug; 19(5):426-32. PubMed ID: 18167156
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
60. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
